According to ClinicalTrials.gov Nabilone is being used in “clinical trials” as a cure for “cannabis use disorder”. (RUFKM)?
Nabilone, (a.k.a. Cesamet owned by Valeant Pharma) is a synthetic or lab made form of the cannabinoid THC (delta-9-tetrahydrocannabinol), the active ingredient in cannabis. Coincidentally, this lab based form resembles the street based synthetic THC known as “spice”or “K2” and is being sold as an incense. K2 or Spice is NOT a natural form of anything, least of all, cannabis. Anything made in a lab, such as spice/k2 is dangerous.
The scientist credited with manufacturing synthetic THC in a lab is – John W Hoffman, PhD, a retired Clemson University chemist whose initials, JWH, is linked with the synthetic cannabinoid JWH-018, a.k.a. Spice.
It should be noted that in 2007, Valeant Pharma acquired the commercial rights to nabilone in the United Kingdom and other EU markets at a cost of $14 million. http://www.businesswire.com/news/home/20070215005880/en/Valeant-Pharmaceuticals-Acquires-Rights-Nabilone-United-Kingdom
“The DSM – (Diagnostic and Statistical Manual of Mental Disorders) is said to be the standard classification of mental disorders used for clinical, research, policy, and reimbursement purposes in the United States and elsewhere. It therefore has widespread importance and influence on how disorders are diagnosed, treated, and investigated. Since its first publication in 1952, DSM has been reviewed and revised four times; the criteria in the last version, DSM-IV-TR, were first published in 1994. Since then, knowledge about psychiatric disorders, including substance use disorders, has advanced greatly. To take the advances into account, a new version, DSM-5, was published in 2013.” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767415/